Alexandre Bejanin
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 106 publications
APOEε4 attenuates early TREM2-mediated microglial responses and influences disease trajectories in dementia with Lewy bodies.
Journal: Research square
Published: August 20, 2026
Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases.
Journal: medRxiv : the preprint server for health sciences
Published: July 17, 2026
Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.
Journal: JAMA
Published: July 13, 2026
Clinical Impact and Prognostic Value of Alzheimer Disease Biomarkers in the Very Old.
Journal: Neurology
Published: June 17, 2026
Association of neighborhood deprivation with Alzheimer's Disease pathology, brain structure, and cognition by race and ethnicity, sex, and APOE ε4 status.
Journal: medRxiv : the preprint server for health sciences
Published: May 18, 2026
Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer's disease.
Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026
Methodological insights and clinical outcomes in ALS and FTLD: lessons from the SPIN cohort.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 10, 2026
Semantic control across Alzheimer's disease phenotypes: cognitive mechanisms and neural correlates.
Journal: Frontiers in aging neuroscience
Published: March 02, 2026
Bilingualism's protective effects in Alzheimer's disease: Mechanisms of resilience and resistance.
Journal: medRxiv : the preprint server for health sciences
Published: February 27, 2026
Bilingualism's protective effects in Alzheimer's disease: Mechanisms of resilience and resistance.
Journal: medRxiv : the preprint server for health sciences
Published: February 27, 2026
Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases.
Journal: EBioMedicine
Published: February 16, 2026
CSF and plasma tau biomarkers in the Down syndrome-Alzheimer's disease continuum.
Journal: EBioMedicine
Published: January 22, 2026
Last Updated: 09/26/2026